ATE433443T1 - Neue kristalline und stabile form von andolast - Google Patents

Neue kristalline und stabile form von andolast

Info

Publication number
ATE433443T1
ATE433443T1 AT06112427T AT06112427T ATE433443T1 AT E433443 T1 ATE433443 T1 AT E433443T1 AT 06112427 T AT06112427 T AT 06112427T AT 06112427 T AT06112427 T AT 06112427T AT E433443 T1 ATE433443 T1 AT E433443T1
Authority
AT
Austria
Prior art keywords
andolast
new crystalline
stable form
conditions
disodium
Prior art date
Application number
AT06112427T
Other languages
English (en)
Inventor
Antonio Giordani
Paolo Senin
Francesco Makovec
Walter Peris
Lucio Claudio Rovati
Antonino Santoro
Matteo Ghirri
Paola Gilotta
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of ATE433443T1 publication Critical patent/ATE433443T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicinal Preparation (AREA)
AT06112427T 2006-04-10 2006-04-10 Neue kristalline und stabile form von andolast ATE433443T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112427A EP1845093B1 (de) 2006-04-10 2006-04-10 Neue kristalline und stabile Form von Andolast

Publications (1)

Publication Number Publication Date
ATE433443T1 true ATE433443T1 (de) 2009-06-15

Family

ID=36942320

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06112427T ATE433443T1 (de) 2006-04-10 2006-04-10 Neue kristalline und stabile form von andolast

Country Status (11)

Country Link
US (2) US7824710B2 (de)
EP (1) EP1845093B1 (de)
JP (1) JP5265876B2 (de)
AT (1) ATE433443T1 (de)
AU (1) AU2007200816B2 (de)
CA (1) CA2579333A1 (de)
DE (1) DE602006007211D1 (de)
DK (1) DK1845093T3 (de)
ES (1) ES2327265T3 (de)
PL (1) PL1845093T3 (de)
PT (1) PT1845093E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7444197B2 (en) * 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232252B (it) 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
DE69722610T2 (de) * 1997-08-08 2004-04-29 Rotta Research Laboratorium S.P.A., Monza Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
EP1634595B1 (de) 2004-08-19 2008-08-13 Rottapharm S.p.A. Verwendung von Phenylbenzamide-derivaten zur Behandlung von chronisch-obstruktiver Lungenerkrankung (COPD)

Also Published As

Publication number Publication date
AU2007200816B2 (en) 2012-11-01
PL1845093T3 (pl) 2009-11-30
ES2327265T3 (es) 2009-10-27
US20110086896A1 (en) 2011-04-14
EP1845093A1 (de) 2007-10-17
US7824710B2 (en) 2010-11-02
PT1845093E (pt) 2009-08-17
JP2007277228A (ja) 2007-10-25
DE602006007211D1 (de) 2009-07-23
US20070149586A1 (en) 2007-06-28
AU2007200816A1 (en) 2007-10-25
EP1845093B1 (de) 2009-06-10
CA2579333A1 (en) 2007-10-10
JP5265876B2 (ja) 2013-08-14
DK1845093T3 (da) 2009-09-14

Similar Documents

Publication Publication Date Title
ES2362788T3 (es) Compuesto de indolina y proceso para la producción del mismo.
DE602004019881D1 (de) Kristallformen der zoledronsäure und deren natrioumsalze, amorphes natriumzoledronat und verfahren zu deren herstellung
HRP20161477T1 (hr) Ligandi koji vežu opsin, pripravci i postupci uporabe
BRPI0506906A (pt) composição farmacêutica sólida estável, processos para a estabilização de um sal, e para a preparação de um sal cristalino, e, sal cristalino
CY1112276T1 (el) Παραγωγα (3-αμινο-1,2,3,4-τετραϋδρο-9h-καρβαζολ-9-υλ)- οξικου οξεος
ES2314593T3 (es) Forma cristalina alfa de ranelato de estroncio, su procedimiento de preparacion y composiciones farmaceuticas que la contienen.
ATE433443T1 (de) Neue kristalline und stabile form von andolast
EP1818329A4 (de) (s)-(-)-1-(4-fluorisochinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazinhydrochlorid- dihydrat
Murugan et al. Control of Liquid–Liquid Phase Separation, Nucleation, and Growth of L‐Menthol Single Crystals from Water–Ethanol Solvent Mixtures
PT1225174E (pt) Cristais de mirtazapina anidros e processo para a sua producao
HUP0101230A2 (hu) Eljárás 2-[(2-piridil)-metilszulfinil]-1H-benzimidazol-származékok előállítására
KR100818753B1 (ko) 에스오메프라졸 스트론튬염 또는 이의 수화물, 이의제조방법 및 이를 포함하는 약학 조성물
Fini et al. Thermal analysis of some diclofenac salts with alkyl and alkylhydroxy amines
RU2009126578A (ru) Термочувствительный раствор фосфата алюминия, способ его получения и его применение
PE20010209A1 (es) Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas
AR056721A1 (es) Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato
Gordin ON THE CRYSTALLINE ALKALOID OF CALYCANTHUS GLAUCUS. THIRD PAPER.—ON ISOCALYCANTHINE, ISOMERIC WITH CALYCANTHINE.
HRP20250341T1 (hr) Spoj, njegova farmaceutski prihvatljiva sol ili njegov optički izomer, postupak za njegovu proizvodnju, i farmaceutski pripravak za prevenciju ili liječenje virusnih bolesti, koji sadrži taj spoj kao aktivni sastojak
WO2020169971A1 (en) Solidification or crystallisation method
PE20010155A1 (es) Polimorfos de un citrato de azobiciclo [2.2.2]oct-3-ilamina cristalino y sus composiciones farmaceuticas
Shao et al. Determination and correlation of solubility of phenylphosphonic acid in selected solvents
ES2441970T3 (es) Método para producir lansoprazol
ATE522505T1 (de) Benzensulfonamid-verbindungen zur behandlung von erkrankungen, die auf dopamin-d3- rezeptormodulation ansprechen
Pope et al. LXXIX.—The alkaloidal salts of phenylmethylphosphinic acid
BRPI0518135A (pt) composição, processo para preparar maltitol cristalino, e, produto de maltitol cristalino

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1845093

Country of ref document: EP